Comparative Pharmacology
Head-to-head clinical analysis: TENUATE versus TEPANIL TEN TAB.
Peer-Reviewed Evidence
Head-to-head clinical analysis: TENUATE versus TEPANIL TEN TAB.
TENUATE vs TEPANIL TEN-TAB
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Tenuate (diethylpropion) is a sympathomimetic amine that acts as an appetite suppressant. It stimulates the release of norepinephrine and to a lesser extent dopamine from presynaptic nerve terminals in the hypothalamus, increasing satiety.
TEPANIL TEN-TAB (diethylpropion hydrochloride controlled-release) is a sympathomimetic amine anorectic agent. It acts primarily on the central nervous system to suppress appetite, likely via stimulation of the hypothalamus to release norepinephrine and dopamine, leading to decreased food intake. The exact molecular mechanism involves inhibition of norepinephrine and dopamine reuptake in the synaptic cleft, increasing their concentrations in the central nervous system.
25 mg orally three times daily before meals, or 75 mg extended-release orally once daily in the morning.
25 mg orally three times daily, 1 hour before meals; for sustained-release, 75 mg orally once daily in the morning.
None Documented
None Documented
4-6 hours (terminal); clinical context: short half-life supports multiple daily dosing
Terminal elimination half-life is 4-6 hours. Clinical context: Steady state is achieved within 1-2 days.
Renal (90% as metabolites, ~10% unchanged); minor biliary/fecal (<10%)
Renal excretion accounts for 60-80% of the dose. Biliary/fecal elimination is approximately 10-20%.
Category C
Category C
Sympathomimetic anorectic
Sympathomimetic anorectic